Fundamentals · HON
Growth Metrics for HON
AI-generated plain-English read of growth metrics for HON. Updated daily.
Low growth, decelerating with margin compression
highLow growth decelerating (-2.7% YoY down from 4.2%): heading toward zero or negative growth; without a specific catalyst this is a deteriorating top-line story.
What will probably happen
- Growth is decelerating: without a reversal catalyst, the next quarter is likely to show further moderation in the top line.
- Earnings lagging revenue growth signals margin compression: the company is growing the top line but spending more to do it; watch gross margin and SG&A trends closely.
- Highly erratic growth pattern: quarter-to-quarter volatility makes forecasting unreliable and reduces the quality of any single-period read.
What to do
- If you HOLD this stock
- Decelerating revenue paired with earnings quality deterioration: exit unless your thesis hinges on a specific upcoming catalyst; multiple risks are compounding.
- If you're EVALUATING this stock
- Wait for stabilization: entering into a decelerating growth story adds more risk than the valuation discount typically compensates for. Look for one quarter of stabilization before initiating.
- If you trade OPTIONS
- Long puts or put spreads. Deceleration paired with earnings quality deterioration is directionally bearish.
9 periods of income data with recent reporting: trend reads are reliable.
Technical details
Technical analysis
- Revenue YoY growth
- -2.7%
- Revenue growth tier
- Low
- Trajectory
- Decelerating
- Earnings YoY growth
- -17.1%
- FCF YoY growth
- 3.8%
- Earnings quality
- Earnings Lag
- Growth consistency (CV)
- 1.16
- Consistency tier
- Erratic
- Prior-avg revenue growth (2y)
- 4.2%
- Income periods
- 9
- Cash flow periods
- 13
- Latest data date
- 2025-12-31T00:00:00
Key levels
| Level | Value |
|---|---|
| revenue yoy | -0.027 |
| earnings yoy | -0.171 |
| fcf yoy | 0.038 |
| prior avg rev growth | 0.042 |
| cv revenue | 1.155 |
| watch growth rate | -0.027 |
Caveats
- Growth comparisons can be skewed by acquisitions, divestitures, or one-off items. Cross-check organic growth disclosures.